BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11597545)

  • 41. Cardiovascular safety of sildenafil.
    Tran D; Howes LG
    Drug Saf; 2003; 26(7):453-60. PubMed ID: 12735784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the solubility and pharmacokinetics of sildenafil salts.
    Jung SY; Seo YG; Kim GK; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2011 Mar; 34(3):451-4. PubMed ID: 21547677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group.
    Tan HM; Moh CL; Mendoza JB; Gana T; Albano GJ; de la Cruz R; Chye PL; Sam CC
    Urology; 2000 Oct; 56(4):635-40. PubMed ID: 11018621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sildenafil in patients with cardiovascular disease.
    Brindis RG; Kloner RA
    Am J Cardiol; 2003 Nov; 92(9A):26M-36M. PubMed ID: 14609621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.
    Ozdal OL; Ozden C; Gokkaya S; Urgancioglu G; Aktas BK; Memis A
    Int Urol Nephrol; 2008; 40(1):133-6. PubMed ID: 17764032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms.
    Lagoda G; Jin L; Lehrfeld TJ; Liu T; Burnett AL
    J Sex Med; 2007 Jul; 4(4 Pt 1):908-16. PubMed ID: 17627738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.
    Muirhead GJ; Wulff MB; Fielding A; Kleinermans D; Buss N
    Br J Clin Pharmacol; 2000 Aug; 50(2):99-107. PubMed ID: 10930961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient renal effects of sildenafil in male kidney transplant recipients.
    Malavaud B; Rostaing L; Tran-Van T; Tack I; Ader JL
    Transplantation; 2001 Oct; 72(7):1331-3. PubMed ID: 11602866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of sildenafil citrate on human hemodynamics.
    Jackson G; Benjamin N; Jackson N; Allen MJ
    Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury.
    Derry FA; Dinsmore WW; Fraser M; Gardner BP; Glass CA; Maytom MC; Smith MD
    Neurology; 1998 Dec; 51(6):1629-33. PubMed ID: 9855514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sildenafil (Viagra) for the treatment of erectile dysfunction in men with diabetes.
    Setter SM; Baker DE; Campbell RK; Johnson SB
    Diabetes Educ; 1999; 25(1):79-80, 83-4, 87 passim. PubMed ID: 10232183
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.
    Stavros F; Kramer WG; Wilkins MR
    Br J Clin Pharmacol; 2010 Jan; 69(1):23-6. PubMed ID: 20078609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men.
    Mahmud A; Hennessy M; Feely J
    J Hum Hypertens; 2001 Oct; 15(10):707-13. PubMed ID: 11607801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.
    Bivalacqua TJ; Usta MF; Champion HC; Leungwattanakij S; Dabisch PA; McNamara DB; Kadowitz PJ; Hellstrom WJ
    Int J Impot Res; 2004 Feb; 16(1):21-9. PubMed ID: 14963467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis.
    Fowler CJ; Miller JR; Sharief MK; Hussain IF; Stecher VJ; Sweeney M
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):700-5. PubMed ID: 15834030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial.
    Arruda-Olson AM; Mahoney DW; Nehra A; Leckel M; Pellikka PA
    JAMA; 2002 Feb; 287(6):719-25. PubMed ID: 11851538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adverse events and drug interactions of sildenafil].
    Hisasue S; Sato Y; Tsukamoto T
    Nihon Rinsho; 2002 Jun; 60 Suppl 6():266-70. PubMed ID: 12166154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.